𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RESPONSIBILITY AFTER THE APPARENT END: ‘FOLLOWING-UP’ IN CLINICAL ETHICS CONSULTATION

✍ Scribed by STUART G. FINDER; MARK J. BLITON


Book ID
110974566
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
137 KB
Volume
25
Category
Article
ISSN
0269-9702

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Five-year clinical follow-up after impla
✍ Ian T. Meredith; John Ormiston; Robert Whitbourn; I. Patrick Kay; David Muller; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract Objective: To evaluate the 5‐year clinical outcomes of patients treated with the Endeavor zotarolimus‐eluting stent (ZES) in the ENDEAVOR I first‐in‐human study. Background: ENDEAVOR I was a prospective, nonrandomized, multicenter study of the Endeavor ZES in 100 consecutive patients wi

A randomized clinical trial of single-do
✍ Beatriz De Camargo; Eduardo L. Franco; Brazilian Wilms' Tumor Study Group 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

for the Brazilian Wilms' Tumor Study Group$ Background. To verify the adequacy of a simplified chemotherapeutic regimen for the treatment of Wilms' tumor (WT), the authors conducted a clinical trial to compare the standard fractionated dose (15 mcg/kg x 5 days) of dactinomycin (AMD) with a single do